Diagnostic ultrasound ( PDFDrive )

1440 PART IV Obstetric and Fetal Sonography
122. Senat MV, Deprest J, Boulvain M, et al. Endoscopic laser surgery versus
serial amnioreduction for severe twin-to-twin transfusion syndrome. N
Engl J Med. 2004;351(2):136-144.
123. Quintero RA, Dickinson JE, Morales WJ, et al. Stage-based treatment of
twin-twin transfusion syndrome. Am J Obstet Gynecol. 2003;188(5):
1333-1340.
124. Gebb J, Dar P, Rosner M, Evans MI. Long-term neurologic outcomes ater
common fetal interventions. Am J Obstet Gynecol. 2015;212(4):527.e1-527.
e9.
125. Moore T, Gale S, Benirschke K. Perinatal outcome of forty-nine pregnancies
complicated by acardiac twinning. Am J Obstet Gynecol. 1990;163(3):
907-912.
126. Quintero RA, Reich H, Puder KS, et al. Brief report: umbilical-cord ligation
of an acardiac twin by fetoscopy at 19 weeks of gestation. N Engl J Med.
1994;330(7):469-471.
127. Peeters S, Devlieger R, Middeldorp J, et al. Fetal surgery in complicated
monoamniotic pregnancies: case series and systematic review of the literature.
Prenat Diagn. 2014;34(6):586-591.
128. Tan TYT, Sepulveda W. Acardiac twin: a systematic review of minimally
invasive treatment modalities. Ultrasound Obstet Gynecol. 2003;22(4):
409-419.
129. Hirose M, Murata A, Kita N, et al. Successful intrauterine treatment with
radiofrequency ablation in a case of acardiac twin pregnancy complicated
with a hydropic pump twin. Ultrasound Obstet Gynecol. 2004;23(5):
509-512.
130. Tsao K, Feldstein VA, Albanese CT, et al. Selective reduction of acardiac
twin by radiofrequency ablation. Am J Obstet Gynecol. 2002;187(3):
635-640.
131. Ville Y, Hyett JA, Vandenbussche FP, Nicolaides KH. Endoscopic laser
coagulation of umbilical cord vessels in twin reversed arterial perfusion
sequence. Ultrasound Obstet Gynecol. 1994;4(5):396-398.
132. Rodeck C, Deans A, Jauniaux E. hermocoagulation for the early treatment
of pregnancy with an acardiac twin. N Engl J Med. 1998;339(18):
1293-1295.
133. Lee H, Bebbington M, Crombleholme TM. North American Fetal herapy
Network. he North American Fetal herapy Network Registry data on
outcomes of radiofrequency ablation for twin-reversed arterial perfusion
sequence. Fetal Diagn her. 2013;33(4):224-229.
134. Iskaros J, Jauniaux E, Rodeck C. Outcome of nonimmune hydrops fetalis
diagnosed during the irst half of pregnancy. Obstet Gynecol. 1997;90(3):
321-325.
135. McCoy MC, Katz VL, Gould N, Kuller JA. Non-immune hydrops ater 20
weeks’ gestation: review of 10 years’ experience with suggestions for management.
Obstet Gynecol. 1995;85(4):578-582.
136. Has R. Non-immune hydrops fetalis in the irst trimester: a review of 30
cases. Clin Exp Obstet Gynecol. 2001;28(3):187-190.
137. Hojo S, Tsukimori K, Kitade S, et al. Prenatal sonographic indings and
hematological abnormalities in fetuses with transient abnormal myelopoiesis
with Down syndrome. Prenat Diagn. 2007;27(6):507-511.
138. Zerres K, Schwanitz G, Niesen M, et al. Prenatal diagnosis of acute nonlymphoblastic
leukaemia in Down syndrome. Lancet. 1990;335(8681):117.
139. Hyett JA, Perdu M, Sharland GK, et al. Increased nuchal translucency at
10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound
Obstet Gynecol. 1997;10(4):242-246.
140. Jenderny J, Schmidt W, Hecher K, et al. Increased nuchal translucency,
hydrops fetalis or hygroma colli. A new test strategy for early fetal aneuploidy
detection. Fetal Diagn her. 2001;16(4):211-214.
141. Hedrick HL, Flake AW, Crombleholme TM, et al. Sacrococcygeal teratoma:
prenatal assessment, fetal intervention, and outcome. J Pediatr Surg.
2004;39(3):430-438.
142. Sananes N, Javadian P, Britto IS, et al. Technical aspects and efectiveness
of percutaneous fetal therapies for large sacrococcygeal teratomas—a cohort
study and a literature review. Ultrasound Obstet Gynecol. 2015.
143. Van Mieghem T, Al-Ibrahim A, Deprest J, et al. Minimally invasive therapy
for fetal sacrococcygeal teratoma: case series and systematic review of the
literature. Ultrasound Obstet Gynecol. 2014;43(6):611-619.
144. Dame C, Albers N, Hasan C, et al. Homozygous alpha-thalassaemia and
hypospadias—common aetiology or incidental association? Long-term
survival of Hb Bart’s hydrops syndrome leads to new aspects for counselling
of alpha-thalassaemic traits. Eur J Pediatr. 1999;158(3):217-220.
145. Kempe A, Rosing B, Berg C, et al. First-trimester treatment of fetal anemia
secondary to parvovirus B19 infection. Ultrasound Obstet Gynecol. 2007;
29(2):226-228.
146. Perkins RP. Hydrops fetalis and stillbirth in a male glucose-6-phosphate
dehydrogenase-deicient fetus possibly due to maternal ingestion of sulisoxazole;
a case report. Am J Obstet Gynecol. 1971;111(3):379-381.
147. Lallemand AV, Doco-Fenzy M, Gaillard DA. Investigation of nonimmune
hydrops fetalis: multidisciplinary studies are necessary for diagnosis—review
of 94 cases. Pediatr Dev Pathol. 1999;2(5):432-439.
148. Rodriguez MM, Chaves F, Romaguera RL, et al. Value of autopsy in nonimmune
hydrops fetalis: series of 51 stillborn fetuses. Pediatr Dev Pathol.
2002;5(4):365-374.
149. Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol.
1995;19(6):493-501.
150. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial
cells. Lancet. 1988;1(8584):535-536.
151. Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of
non-immune hydrops fetalis secondary to fetal parvovirus B19 infection.
Prenat Diagn. 1989;9(2):105-114.
152. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological
features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol.
1992;99(7):566-574.
153. Oyer CE, Ongcapin EH, Ni J, et al. Fatal intrauterine adenoviral endomyocarditis
with aortic and pulmonary valve stenosis: diagnosis by polymerase
chain reaction. Hum Pathol. 2000;31(11):1433-1435.
154. Bates Jr HR. Coxsackie virus B3 calciic pancarditis and hydrops fetalis.
Am J Obstet Gynecol. 1970;106(4):629-630.
155. von Kaisenberg CS, Jonat W. Fetal parvovirus B19 infection. Ultrasound
Obstet Gynecol. 2001;18(3):280-288.
156. Gray ES, Davidson RJ, Anand A. Human parvovirus and fetal anaemia.
Lancet. 1987;1(8542):1144.
157. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome
of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol.
1998;105(2):174-178.
158. Bhal PS, Davies NJ, Westmoreland D, Jones A. Spontaneous resolution of
non-immune hydrops fetalis secondary to transplacental parvovirus B19
infection. Ultrasound Obstet Gynecol. 1996;7(1):55-57.
159. Pryde PG, Nugent CE, Pridjian G, et al. Spontaneous resolution of nonimmune
hydrops fetalis secondary to human parvovirus B19 infection. Obstet
Gynecol. 1992;79(5 Pt 2):859-861.
160. Humphrey W, Magoon M, O’Shaughnessy R. Severe nonimmune
hydrops secondary to parvovirus B-19 infection: spontaneous reversal in
utero and survival of a term infant. Obstet Gynecol. 1991;78(5 Pt 2):
900-902.
161. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in
human sera. Lancet. 1975;1(7898):72-73.
162. Kovacs BW, Carlson DE, Shahbahrami B, Platt LD. Prenatal diagnosis of
human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain
reaction. Am J Obstet Gynecol. 1992;167(2):461-466.
163. Nagel HT, de Haan TR, Vandenbussche FP, et al. Long-term outcome ater
fetal transfusion for hydrops associated with parvovirus B19 infection.
Obstet Gynecol. 2007;109(1):42-47.
164. Dembinski J, Haverkamp F, Maara H, et al. Neurodevelopmental outcome
ater intrauterine red cell transfusion for parvovirus B19-induced fetal
hydrops. BJOG. 2002;109(11):1232-1234.
165. De Jong EP, Lindenburg IT, van Klink JM, et al. Intrauterine transfusion
for parvovirus B19 infection: long-term neurodevelopmental outcome. Am
J Obstet Gynecol. 2012;206(3):204.e1-204.e5.
166. Dafos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of
746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med.
1988;318(5):271-275.
167. Friedman S, Ford-Jones LE, Toi A, et al. Congenital toxoplasmosis: prenatal
diagnosis, treatment and postnatal outcome. Prenat Diagn. 1999;
19(4):330-333.
168. Zornes SL, Anderson PG, Lott RL. Congenital toxoplasmosis in an infant
with hydrops fetalis. South Med J. 1988;81(3):391-393.